Most peptide research was conducted on men. Most longevity protocols were designed for men. Most dosing guidelines, most cycling recommendations, most clinical observations — all drawn from male biology, male hormones, and male metabolic patterns.
For Australian women navigating hormonal shifts, skin changes, energy decline, and the complex biology of perimenopause and beyond, this gap matters. And it's closing — slowly, but meaningfully — as researchers begin to examine how peptide compounds interact with female physiology specifically.
This is the guide we wish existed earlier. A complete, evidence-referenced breakdown of the peptides most relevant to women's longevity science in Australia — what they are, what the research shows, how they interact with female biology, and how to approach them intelligently.
What Are Peptides?
Peptides are short chains of amino acids — the building blocks of proteins. Unlike full proteins, their small molecular size means they can interact directly with cell receptors, signalling pathways, and biological processes that larger molecules cannot reach.
The human body produces thousands of peptides naturally. Many function as signalling molecules: telling cells to repair, regenerate, produce collagen, regulate inflammation, or adjust hormone sensitivity. As we age — and particularly as women approach perimenopause — the body's natural peptide production declines, often dramatically.
Research-grade peptide compounds are synthesised versions of these naturally occurring sequences, or novel sequences designed to mimic and amplify specific biological signals. In a research context, they offer a targeted approach to biological processes that broad-spectrum interventions (like HRT or standard supplementation) cannot address with the same precision.
In Australia, research-grade peptides are sold strictly for laboratory research purposes. They are not approved as therapeutic agents by the TGA for human use without a prescription from a qualified medical practitioner. Always consult a healthcare professional before beginning any new health protocol.
Why Women Need Different Peptide Protocols
The case for female-specific peptide research is not ideological — it's physiological. Women's biology differs from men's in ways that directly affect how peptide compounds interact with the body:
- Hormonal architecture: Oestrogen, progesterone, and testosterone fluctuate dramatically across a woman's lifespan in ways that affect receptor sensitivity, collagen production, inflammation response, and metabolic rate.
- Perimenopause accelerates biological ageing: The hormonal shift of perimenopause (typically beginning in the mid-40s) is not gradual — it triggers rapid changes in skin thickness, bone density, cognitive function, sleep architecture, and metabolic efficiency. Standard longevity protocols designed for stable male hormonal environments do not account for this acceleration.
- Body composition differences: Women have higher baseline body fat percentages and different muscle-to-fat distribution, which affects how peptides are absorbed, distributed, and metabolised.
- Inflammatory response: Female immune systems are more reactive, which can mean different inflammatory cascades and therefore different responses to peptides that modulate inflammation (such as BPC-157).
The research is beginning to reflect this. Studies examining GHK-Cu in skin science, NAD+ in mitochondrial function, and Epithalon in telomere length are increasingly noting sex-specific variables. Women deserve protocols built on that data — not adapted from protocols designed for 25-year-old male athletes.
The Six Compounds Most Relevant to Women's Longevity
1. GHK-Cu (Copper Peptide)
GHK-Cu is one of the most extensively researched peptides in skin science. A naturally occurring copper-binding peptide, it was first isolated from human plasma in the 1970s and has since been the subject of over 50 published studies examining its role in skin regeneration, wound healing, anti-inflammatory activity, and collagen synthesis.
For women, the relevance is significant. Oestrogen plays a critical role in collagen production — women lose approximately 30% of skin collagen in the first five years following menopause, and continue to lose collagen at a rate of roughly 2% per year thereafter. Research suggests GHK-Cu may stimulate fibroblast activity, upregulate collagen I and III synthesis, and activate tissue remodelling pathways that oestrogen decline suppresses.
Studies also indicate GHK-Cu may reduce oxidative stress, modulate gene expression related to ageing, and support DNA repair mechanisms. It is one of the few peptides with a research profile directly relevant to the specific biological changes women experience post-perimenopause.
2. NAD+ (Nicotinamide Adenine Dinucleotide)
NAD+ is not a peptide in the traditional sense — it is a coenzyme found in every cell of the body and is essential for energy metabolism, DNA repair, and cellular communication. We include it here because the research around NAD+ supplementation is among the most compelling in longevity science, and the decline of NAD+ with age has particular implications for women.
NAD+ levels decline by approximately 50% between the ages of 40 and 60. For women, this decline intersects directly with perimenopause: oestrogen influences NAD+ biosynthesis, meaning the hormonal shift of perimenopause can accelerate NAD+ depletion beyond what age alone would produce.
The consequences are systemic: reduced mitochondrial efficiency (manifesting as fatigue), impaired DNA repair, disrupted circadian signalling (sleep disruption), and compromised sirtuin activity — a family of proteins central to longevity. Research suggests that maintaining NAD+ levels may support mitochondrial function, cognitive clarity, and metabolic health — all areas of particular concern for women in midlife.
3. Epithalon (Epitalon)
Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by the St. Petersburg Institute of Bioregulation and Gerontology, where it has been studied for over 40 years. Its primary area of research is telomere biology.
Telomeres — the protective caps on chromosome ends — shorten with each cell division and are a key marker of biological ageing. Research on Epithalon suggests it may activate telomerase, the enzyme responsible for telomere maintenance and repair. Animal studies have shown telomere elongation and increased maximum lifespan. Human research remains limited, but preliminary data is promising.
For women, Epithalon's additional area of interest is its pineal gland interaction. Research suggests it may stimulate melatonin production via pineal regulation — relevant for women experiencing sleep disruption, a near-universal symptom of perimenopause and post-menopause. Some researchers have also examined Epithalon's effects on antioxidant enzyme activity, which declines with age and hormonal change.
4. PT-141 (Bremelanotide)
PT-141 is a melanocortin receptor agonist with a unique mechanism of action among the compounds discussed here. Unlike most sexual health interventions that operate through vascular pathways, PT-141 works centrally — acting on the nervous system rather than the peripheral vascular system.
It is one of the only compounds with research specifically examining female sexual dysfunction. Clinical trials (which formed the basis of the FDA's approval of Vyleesi, a PT-141-based drug, for hypoactive sexual desire disorder in premenopausal women in the US) demonstrated significant improvements in sexual desire and satisfaction compared to placebo.
For women navigating libido changes associated with perimenopause, post-menopause, hormonal contraception, or other factors affecting sexual desire, PT-141 represents a research area with direct female-specific evidence — rare in the peptide space.
5. Retatrutide
Retatrutide is a novel triple-receptor agonist (GLP-1, GIP, and glucagon receptors) currently under investigation for metabolic health and body composition. Phase 2 clinical trials published in The New England Journal of Medicine demonstrated mean weight reductions of up to 24.2% over 48 weeks — exceeding results seen with earlier GLP-1 agonists.
For women, the metabolic context is critical. Perimenopause is associated with a redistribution of body fat (particularly increased visceral adiposity), insulin resistance, and a reduction in resting metabolic rate. These changes are not simply about aesthetics — visceral fat is metabolically active and associated with increased cardiovascular risk. Research compounds targeting multiple metabolic pathways simultaneously may be more relevant to women's midlife metabolic needs than single-receptor interventions.
Retatrutide remains an investigational compound. Research into long-term safety and specific effects on female hormonal environments is ongoing.
6. BPC-157 + TB-500
BPC-157 (Body Protection Compound 157) is derived from a protein found in gastric juice and has been studied extensively in animal models for its effects on tissue repair, gut healing, and inflammation modulation. TB-500 (Thymosin Beta-4) is a peptide with research supporting tendon and muscle repair, angiogenesis, and anti-inflammatory activity.
In combination, the two compounds are often studied together due to complementary mechanisms — BPC-157 supporting local tissue repair and gut integrity, TB-500 supporting systemic repair and cellular migration.
For women, the combination is particularly relevant in two contexts: recovery from physical training (women experience different injury patterns and recovery timelines than men) and gut health (oestrogen decline affects gut microbiome composition and intestinal permeability, areas where BPC-157's research profile is most developed).
Peptides and Perimenopause: The Research Gap That Matters
Perimenopause — the 4–10 year transition preceding menopause — is one of the most biologically significant periods in a woman's life, and one of the least researched in the context of precision longevity interventions.
The symptoms are well documented: brain fog, sleep disruption, skin thinning, weight resistance, mood volatility, joint pain, reduced libido, and fatigue. What is less documented is how targeted peptide research might address the underlying mechanisms driving these symptoms — rather than simply managing them.
The research picture is emerging:
- NAD+ depletion accelerated by oestrogen decline → NAD+ supplementation as a potential support
- Collagen loss triggered by reduced oestrogen → GHK-Cu research on fibroblast stimulation
- Pineal/melatonin disruption causing sleep dysregulation → Epithalon's pineal interaction research
- Libido changes from hormonal shifts → PT-141's central mechanism research
- Metabolic redistribution and insulin resistance → Retatrutide's triple-receptor pathway research
None of this constitutes medical advice, and none of these compounds are approved as perimenopause treatments. But as research tools, they represent a frontier that women deserve to understand — not filtered through protocols designed for men.
How to Choose a Peptide Supplier in Australia
The Australian research peptide market is largely unregulated at the retail level, which means quality varies enormously. When evaluating a supplier, these are the non-negotiable standards to look for:
- Certificates of Analysis (COAs): Every batch should have an independent, third-party COA confirming identity, purity (≥99% by HPLC), and potency. Supplier self-certification is not sufficient.
- GMP-certified manufacturing: Good Manufacturing Practice certification is the baseline for quality control. Without it, there is no assurance of sterile conditions, accurate dosing, or compound integrity.
- Batch traceability: Products should carry batch references traceable to specific manufacturing runs and testing results.
- Transparent sourcing: Reputable suppliers are transparent about where compounds are synthesised and how they are stored and shipped.
- Cold chain integrity: Lyophilised peptides require cold chain storage (2–8°C) from manufacture to dispatch. Suppliers who do not address this in their storage and shipping protocols introduce real risk of compound degradation.
- No therapeutic claims: Legitimate research compound suppliers do not make therapeutic claims. If a supplier is marketing peptides as treatments or cures, that is a regulatory and quality red flag.
At The Renewal Lab, every compound is independently third-party tested to ≥99% purity, manufactured in GMP-certified facilities, and shipped with full batch traceability. Certificates of Analysis are available on request.
Frequently Asked Questions
Are peptides legal in Australia?
Research-grade peptides occupy a specific regulatory category in Australia. They are not approved therapeutic goods for human use unless prescribed by a qualified medical practitioner and obtained through licensed channels. They are sold legally as research compounds for laboratory research purposes. The Renewal Lab sells all compounds strictly for research purposes. Consult a qualified health practitioner before beginning any protocol.
Do I need a prescription to buy research peptides in Australia?
Research-grade peptides sold for laboratory purposes do not require a prescription in Australia. However, if you intend to use peptides therapeutically, you should consult a qualified medical practitioner who can assess your individual situation and, where appropriate, prescribe through licensed compounding pharmacies.
How are research peptides different from the peptides in skincare?
Topical peptides in skincare products are typically too large to penetrate the dermal barrier at meaningful concentrations. Research-grade peptides are purity-verified compounds intended for research applications, with significantly different specifications, storage requirements, and reconstitution protocols.
What peptides are most relevant for women over 40?
Based on the available research, GHK-Cu (collagen and skin science), NAD+ (mitochondrial and metabolic function), and Epithalon (telomere biology and sleep regulation) have the most direct research relevance to the biological changes women experience in the decade either side of menopause. That said, individual biology varies significantly — any protocol should be approached with professional guidance.
How should peptides be stored?
Lyophilised (freeze-dried) peptide powder should be stored at 2–8°C in a refrigerator, away from light and moisture. Once reconstituted with bacteriostatic water, solutions should be kept refrigerated and used within 28–30 days. All The Renewal Lab compounds are dispatched with cold chain packaging.
Does The Renewal Lab ship to New Zealand?
Yes. The Renewal Lab ships research compounds to both Australia and New Zealand. Shipping timelines and import considerations may vary — contact us directly for NZ-specific shipping information.
The Bottom Line
The science of peptides for women is not yet complete. But it is advancing — and the early research is compelling enough that Australian women who take their biology seriously deserve access to quality compounds and honest, evidence-referenced information about what is actually known.
The Renewal Lab exists at this intersection: research-grade compounds, transparent quality standards, and information built for women — not retrofitted from protocols designed for men.
Longevity science should not have a gender gap. We're here to help close it.
Ready to start your protocol?
Research-grade compounds. Formulated for female biology. Ships across Australia and New Zealand.
Explore the Range